Related references
Note: Only part of the references are listed.GS-0976 (Firsocostat): an investigational liver-directed acetyl-CoA carboxylase (ACC) inhibitor for the treatment of non-alcoholic steatohepatitis (NASH)
Naim Alkhouri et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2020)
AMPK and TOR: The Yin and Yang of Cellular Nutrient Sensing and Growth Control
Asier Gonzalez et al.
CELL METABOLISM (2020)
An AMPK-caspase-6 axis controls liver damage in nonalcoholic steatohepatitis
Peng Zhao et al.
SCIENCE (2020)
Nicotinamide and its metabolite N1-Methylnicotinamide alleviate endocrine and metabolic abnormalities in adipose and ovarian tissues in rat model of Polycystic Ovary Syndrome
Hamid Reza Nejabati et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2020)
From overnutrition to liver injury: AMP-activated protein kinase in nonalcoholic fatty liver diseases
Peng Zhao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
N1-Methylnicotinamide: An Anti-Ovarian Aging Hormetin?
Hamid Reza Nejabati et al.
AGEING RESEARCH REVIEWS (2020)
The Role of Fibrosis and Liver-Associated Fibroblasts in the Pathogenesis of Hepatocellular Carcinoma
Jacopo Baglieri et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Vanillic Acid Restores Coenzyme Q Biosynthesis and ATP Production in Human Cells Lacking COQ6
Manuel J. Acosta Lopez et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2019)
Molecular pathways of nonalcoholic fatty liver disease development and progression
Fernando Bessone et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2019)
Genetic Liver-Specific AMPK Activation Protects against Diet-Induced Obesity and NAFLD
Daniel Garcia et al.
CELL REPORTS (2019)
mTORC1 signaling in hepatic lipid metabolism
Jinbo Han et al.
PROTEIN & CELL (2018)
Vanillic acid attenuates obesity via activation of the AMPK pathway and thermogenic factors in vivo and in vitro
Yunu Jung et al.
FASEB JOURNAL (2018)
Matrix metalloproteinases and liver fibrosis (translational aspects)
Elke Roeb
MATRIX BIOLOGY (2018)
Triggering and resolution of inflammation in NASH
Susanne Schuster et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
Vanillic acid activates thermogenesis in brown and white adipose tissue
Xue Han et al.
FOOD & FUNCTION (2018)
AMPK: a novel target for treating hepatic fibrosis
Zhenxing Liang et al.
ONCOTARGET (2017)
AMPK Maintains Cellular Metabolic Homeostasis through Regulation of Mitochondrial Reactive Oxygen Species
Rebecca C. Rabinovitch et al.
CELL REPORTS (2017)
Mesenteric Fat Lipolysis Mediates Obesity-Associated Hepatic Steatosis and Insulin Resistance
Stephan Wueest et al.
DIABETES (2016)
Treatment of nonalcoholic fatty liver disease: role of AMPK
Brennan K. Smith et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2016)
Global Epidemiology of Nonalcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes
Zobair M. Younossi et al.
HEPATOLOGY (2016)
Prevalence of Nonalcoholic Fatty Liver Disease and Economy
Jin-Zhou Zhu et al.
DIGESTIVE DISEASES AND SCIENCES (2015)
Curcumin regulates peroxisome proliferator-activated receptor-γ coactivator-1α expression by AMPK pathway in hepatic stellate cells in vitro
Xuguang Zhai et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2015)
Adiponectin attenuates liver fibrosis by inducing nitric oxide production of hepatic stellate cells
Zhixia Dong et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2015)
AMPK at the Nexus of Energetics and Aging
Kristopher Burkewitz et al.
CELL METABOLISM (2014)
Toll-like receptor-4 signalling in the progression of non-alcoholic fatty liver disease induced by high-fat and high-fructose diet in mice
Jing Liu et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2014)
Adiponectin Agonist ADP355 Attenuates CCl4-Induced Liver Fibrosis in Mice
Pradeep Kumar et al.
PLOS ONE (2014)
TGF-β1 Up-Regulates the Expression of PDGF-b Receptor mRNA and Induces a Delayed PI3K-, AKT-, and p70 S6K-Dependent Proliferative Response in Activated Hepatic Stellate Cells
Ruchi Shah et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2013)
AMPK: A Contextual Oncogene or Tumor Suppressor?
Jiyong Liang et al.
CANCER RESEARCH (2013)
Increased hepatic de novo lipogenesis and mitochondrial efficiency in a model of obesity induced by diets rich in fructose
Raffaella Crescenzo et al.
EUROPEAN JOURNAL OF NUTRITION (2013)
Inflammation as a potential link between nonalcoholic fatty liver disease and insulin resistance
Mohamed Asrih et al.
JOURNAL OF ENDOCRINOLOGY (2013)
Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease
Yuki Kawano et al.
JOURNAL OF GASTROENTEROLOGY (2013)
Antioxidative Properties of Vanillic Acid Esters in Multiple Antioxidant Assays
Akihiro Tai et al.
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY (2012)
Thiazolidinediones improve hepatic fibrosis in rats with non-alcoholic steatohepatitis by activating the adenosine monophosphate-activated protein kinase signalling pathway
Wei Zhang et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2012)
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
Naga Chalasani et al.
HEPATOLOGY (2012)
Insulin sensitive and resistant obesity in humans: AMPK activity, oxidative stress, and depot-specific changes in gene expression in adipose tissue
X. Julia Xu et al.
JOURNAL OF LIPID RESEARCH (2012)
Misregulation of PPAR Functioning and Its Pathogenic Consequences Associated with Nonalcoholic Fatty Liver Disease in Human Obesity
Luis A. Videla et al.
PPAR RESEARCH (2012)
Diet high in fat and sucrose induces rapid onset of obesity-related metabolic syndrome partly through rapid response of genes involved in lipogenesis, insulin signalling and inflammation in mice
Zhi-Hong Yang et al.
DIABETOLOGY & METABOLIC SYNDROME (2012)
The Role of Diet and Nutrient Composition in Nonalcoholic Fatty Liver Disease
Erin Marie McCarthy et al.
JOURNAL OF THE ACADEMY OF NUTRITION AND DIETETICS (2012)
Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
J. K. Dowman et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Mechanisms of hepatic fibrogenesis
Ursula E. Lee et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2011)
AMPK Phosphorylates and Inhibits SREBP Activity to Attenuate Hepatic Steatosis and Atherosclerosis in Diet-Induced Insulin-Resistant Mice
Yu Li et al.
CELL METABOLISM (2011)
Non-invasive diagnosis of nonalcoholic fatty liver and nonalcoholic steatohepatitis
Leon A. Adams et al.
JOURNAL OF DIGESTIVE DISEASES (2011)
Hepatoprotective Effect of Syringic Acid and Vanillic Acid on CCl4-Induced Liver Injury
Ayano Itoh et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2010)
Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c
P. Ferre et al.
DIABETES OBESITY & METABOLISM (2010)
Obesity and Nonalcoholic Fatty Liver Disease: Biochemical, Metabolic, and Clinical Implications
Elisa Fabbrini et al.
HEPATOLOGY (2010)
Randomized Controlled Trial Testing the Effects of Weight Loss on Nonalcoholic Steatohepatitis
Kittichai Promrat et al.
HEPATOLOGY (2010)
Evolution of Inflammation in Nonalcoholic Fatty Liver Disease: The Multiple Parallel Hits Hypothesis
Herbert Tilg et al.
HEPATOLOGY (2010)
Increased Visceral Adipocyte Lipolysis-A Pathogenic Role in Nonalcoholic Fatty Liver Disease?
Anders Thorne et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Hepatocyte Death: A Clear and Present Danger
Harmeet Malhi et al.
PHYSIOLOGICAL REVIEWS (2010)
Hepatoprotective Effect of Syringic Acid and Vanillic Acid on Concanavalin A-Induced Liver Injury
Ayano Itoh et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2009)
PGC-1α, SIRT1 and AMPK, an energy sensing network that controls energy expenditure
Carles Canto et al.
CURRENT OPINION IN LIPIDOLOGY (2009)
Antioxidant phenolic compounds from walnut kernels (Juglans regia L.)
Zijia Zhang et al.
FOOD CHEMISTRY (2009)
Analysis of hepatic genes involved in the metabolism of fatty acids and iron in nonalcoholic fatty liver disease
Hironori Mitsuyoshi et al.
HEPATOLOGY RESEARCH (2009)
Effect of a lifestyle intervention in patients with abnormal liver enzymes and metabolic risk factors
Alexis St. George et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2009)
Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD)
Giovanni Musso et al.
PROGRESS IN LIPID RESEARCH (2009)
Metformin in patients with non-alcoholic fatty liver disease: A randomized, controlled trial
John Willy Haukeland et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2009)
Liver lipid metabolism
P. Nguyen et al.
JOURNAL OF ANIMAL PHYSIOLOGY AND ANIMAL NUTRITION (2008)
AMPK phosphorylation of raptor mediates a metabolic checkpoint
Dana M. Gwinn et al.
MOLECULAR CELL (2008)
Inflammation and metabolic disorders
Goekhan S. Hotamisligil
NATURE (2006)
Diet-induced obesity alters AMP kinase activity in hypothalamus and skeletal muscle
Tonya L. Martin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism
SH Koo et al.
NATURE (2005)
Apoptosis: a mechanism of acute and chronic liver injury
ME Guicciardi et al.
GUT (2005)
Anti-lipolytic action of AMP-activated protein kinase in rodent adipocytes
M Daval et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
AMP kinase and malonyl-CoA: Targets for therapy of the metabolic syndrome
N Ruderman et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
AMPK inhibits fatty acid-induced increases in NF-κB transactivation in cultured human umbilical vein endothelial cells
JM Cacicedo et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Nonalcoholic fatty liver disease - A feature of the metabolic syndrome
G Marchesini et al.
DIABETES (2001)
Share Paper
